nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Blepharoconjunctivitis—Hyoscyamine—pancreatitis	0.316	0.329	CcSEcCtD
Levobunolol—Keratitis—Hyoscyamine—pancreatitis	0.0459	0.0479	CcSEcCtD
Levobunolol—Stinging—Hyoscyamine—pancreatitis	0.0368	0.0383	CcSEcCtD
Levobunolol—Erectile dysfunction—Propantheline—pancreatitis	0.0336	0.035	CcSEcCtD
Levobunolol—Respiratory failure—Hyoscyamine—pancreatitis	0.0303	0.0316	CcSEcCtD
Levobunolol—Nasal congestion—Hyoscyamine—pancreatitis	0.0237	0.0247	CcSEcCtD
Levobunolol—Palpitations—Propantheline—pancreatitis	0.0225	0.0234	CcSEcCtD
Levobunolol—Hypoglycaemia—Hyoscyamine—pancreatitis	0.0222	0.0231	CcSEcCtD
Levobunolol—Lethargy—Hyoscyamine—pancreatitis	0.0221	0.023	CcSEcCtD
Levobunolol—Confusional state—Propantheline—pancreatitis	0.0209	0.0218	CcSEcCtD
Levobunolol—Cardiac arrest—Hyoscyamine—pancreatitis	0.0206	0.0214	CcSEcCtD
Levobunolol—Ataxia—Hyoscyamine—pancreatitis	0.0203	0.0212	CcSEcCtD
Levobunolol—Erectile dysfunction—Hyoscyamine—pancreatitis	0.0172	0.0179	CcSEcCtD
Levobunolol—Feeling abnormal—Propantheline—pancreatitis	0.0171	0.0178	CcSEcCtD
Levobunolol—Depression—Hyoscyamine—pancreatitis	0.0166	0.0173	CcSEcCtD
Levobunolol—Urticaria—Propantheline—pancreatitis	0.0165	0.0172	CcSEcCtD
Levobunolol—Conjunctivitis—Hyoscyamine—pancreatitis	0.0162	0.0169	CcSEcCtD
Levobunolol—Hypersensitivity—Propantheline—pancreatitis	0.0153	0.0159	CcSEcCtD
Levobunolol—Bradycardia—Hyoscyamine—pancreatitis	0.0152	0.0159	CcSEcCtD
Levobunolol—Asthenia—Propantheline—pancreatitis	0.0149	0.0155	CcSEcCtD
Levobunolol—Dizziness—Propantheline—pancreatitis	0.0137	0.0143	CcSEcCtD
Levobunolol—Arrhythmia—Hyoscyamine—pancreatitis	0.0134	0.0139	CcSEcCtD
Levobunolol—Headache—Propantheline—pancreatitis	0.013	0.0136	CcSEcCtD
Levobunolol—Nausea—Propantheline—pancreatitis	0.0123	0.0129	CcSEcCtD
Levobunolol—Syncope—Hyoscyamine—pancreatitis	0.0117	0.0122	CcSEcCtD
Levobunolol—Palpitations—Hyoscyamine—pancreatitis	0.0115	0.012	CcSEcCtD
Levobunolol—Loss of consciousness—Hyoscyamine—pancreatitis	0.0114	0.0119	CcSEcCtD
Levobunolol—Chest pain—Hyoscyamine—pancreatitis	0.0111	0.0116	CcSEcCtD
Levobunolol—Confusional state—Hyoscyamine—pancreatitis	0.0107	0.0112	CcSEcCtD
Levobunolol—Shock—Hyoscyamine—pancreatitis	0.0105	0.0109	CcSEcCtD
Levobunolol—Hypotension—Hyoscyamine—pancreatitis	0.00993	0.0104	CcSEcCtD
Levobunolol—Dyspnoea—Hyoscyamine—pancreatitis	0.00948	0.00988	CcSEcCtD
Levobunolol—Pain—Hyoscyamine—pancreatitis	0.00909	0.00947	CcSEcCtD
Levobunolol—Feeling abnormal—Hyoscyamine—pancreatitis	0.00876	0.00913	CcSEcCtD
Levobunolol—Urticaria—Hyoscyamine—pancreatitis	0.00844	0.0088	CcSEcCtD
Levobunolol—Hypersensitivity—Hyoscyamine—pancreatitis	0.00783	0.00816	CcSEcCtD
Levobunolol—Asthenia—Hyoscyamine—pancreatitis	0.00763	0.00795	CcSEcCtD
Levobunolol—Pruritus—Hyoscyamine—pancreatitis	0.00752	0.00784	CcSEcCtD
Levobunolol—Diarrhoea—Hyoscyamine—pancreatitis	0.00727	0.00758	CcSEcCtD
Levobunolol—Dizziness—Hyoscyamine—pancreatitis	0.00703	0.00732	CcSEcCtD
Levobunolol—Headache—Hyoscyamine—pancreatitis	0.00666	0.00694	CcSEcCtD
Levobunolol—Nausea—Hyoscyamine—pancreatitis	0.00631	0.00658	CcSEcCtD
Levobunolol—ADRB1—G alpha (s) signalling events—PTHLH—pancreatitis	0.000538	0.0133	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—PTHLH—pancreatitis	0.000527	0.013	CbGpPWpGaD
Levobunolol—ADRB2—Arf6 trafficking events—INS—pancreatitis	0.000524	0.013	CbGpPWpGaD
Levobunolol—ADRB1—G alpha (s) signalling events—GCG—pancreatitis	0.000439	0.0109	CbGpPWpGaD
Levobunolol—ADRB2—G alpha (s) signalling events—GCG—pancreatitis	0.000429	0.0106	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.00042	0.0104	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.000411	0.0102	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Other—HTR2A—pancreatitis	0.000389	0.00962	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.000362	0.00894	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.000354	0.00875	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.000352	0.00872	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.000347	0.00857	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.000345	0.00853	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.000339	0.00839	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PPY—pancreatitis	0.00032	0.00791	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.000318	0.00788	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PPY—pancreatitis	0.000313	0.00774	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.000312	0.00771	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.00031	0.00766	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.00031	0.00766	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.000303	0.0075	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.000303	0.0075	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.000302	0.00747	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.000302	0.00747	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.000297	0.00735	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.000295	0.0073	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.000295	0.0073	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.000291	0.00719	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000258	0.00637	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.000253	0.00626	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000252	0.00623	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.000247	0.00612	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—SCT—pancreatitis	0.000247	0.00612	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CASR—pancreatitis	0.000247	0.00612	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CX3CL1—pancreatitis	0.000242	0.006	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—SCT—pancreatitis	0.000242	0.00598	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CASR—pancreatitis	0.000242	0.00598	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CX3CL1—pancreatitis	0.000237	0.00587	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCK—pancreatitis	0.000236	0.00584	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—MTNR1B—pancreatitis	0.000236	0.00584	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.000235	0.00581	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCK—pancreatitis	0.000231	0.00571	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—MTNR1B—pancreatitis	0.000231	0.00571	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CNR2—pancreatitis	0.00023	0.00569	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—TACR1—pancreatitis	0.00023	0.00569	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.00023	0.00568	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCKAR—pancreatitis	0.000226	0.00559	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CNR2—pancreatitis	0.000225	0.00556	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—TACR1—pancreatitis	0.000225	0.00556	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCKAR—pancreatitis	0.000221	0.00547	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.000221	0.00546	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.000217	0.00536	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.000216	0.00534	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.000212	0.00524	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.000201	0.00497	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.000196	0.00486	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—PTHLH—pancreatitis	0.000195	0.00484	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—SMO—pancreatitis	0.000195	0.00484	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—SMO—pancreatitis	0.000191	0.00473	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—PTHLH—pancreatitis	0.000191	0.00473	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PPY—pancreatitis	0.000181	0.00447	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—SST—pancreatitis	0.000179	0.00442	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PPY—pancreatitis	0.000177	0.00438	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—SST—pancreatitis	0.000175	0.00433	CbGpPWpGaD
Levobunolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.000173	0.00427	CbGpPWpGaD
Levobunolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.000169	0.00418	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—BDKRB2—pancreatitis	0.000168	0.00416	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.000168	0.00415	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CNR1—pancreatitis	0.000165	0.00408	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—BDKRB2—pancreatitis	0.000164	0.00407	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.000164	0.00406	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPY—pancreatitis	0.000164	0.00406	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CNR1—pancreatitis	0.000161	0.00399	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPY—pancreatitis	0.000161	0.00397	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—GCG—pancreatitis	0.000159	0.00394	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—GCG—pancreatitis	0.000156	0.00386	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—KNG1—pancreatitis	0.000153	0.00378	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—KNG1—pancreatitis	0.00015	0.0037	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000148	0.00366	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000145	0.00358	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—SCT—pancreatitis	0.00014	0.00346	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CASR—pancreatitis	0.00014	0.00346	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CASR—pancreatitis	0.000137	0.00338	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—SCT—pancreatitis	0.000137	0.00338	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCK—pancreatitis	0.000133	0.0033	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—MTNR1B—pancreatitis	0.000133	0.0033	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCK—pancreatitis	0.00013	0.00323	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—MTNR1B—pancreatitis	0.00013	0.00323	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CNR2—pancreatitis	0.00013	0.00321	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—TACR1—pancreatitis	0.00013	0.00321	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCL5—pancreatitis	0.000128	0.00316	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCKAR—pancreatitis	0.000128	0.00316	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CNR2—pancreatitis	0.000127	0.00314	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—TACR1—pancreatitis	0.000127	0.00314	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—SCT—pancreatitis	0.000127	0.00314	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CASR—pancreatitis	0.000127	0.00314	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCL5—pancreatitis	0.000125	0.00309	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCKAR—pancreatitis	0.000125	0.00309	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CX3CL1—pancreatitis	0.000124	0.00308	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—SCT—pancreatitis	0.000124	0.00307	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CASR—pancreatitis	0.000124	0.00307	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CX3CL1—pancreatitis	0.000122	0.00301	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCK—pancreatitis	0.000121	0.00299	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—MTNR1B—pancreatitis	0.000121	0.00299	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—MTNR1B—pancreatitis	0.000118	0.00293	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCK—pancreatitis	0.000118	0.00293	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CNR2—pancreatitis	0.000118	0.00292	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—TACR1—pancreatitis	0.000118	0.00292	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCKAR—pancreatitis	0.000116	0.00287	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000116	0.00286	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CNR2—pancreatitis	0.000115	0.00285	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—TACR1—pancreatitis	0.000115	0.00285	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCKAR—pancreatitis	0.000114	0.00281	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000113	0.0028	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—HTR2A—pancreatitis	0.000113	0.00279	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—PTHLH—pancreatitis	0.00011	0.00273	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—HTR2A—pancreatitis	0.00011	0.00273	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PNLIP—pancreatitis	0.000108	0.00268	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—PTHLH—pancreatitis	0.000108	0.00267	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PNLIP—pancreatitis	0.000106	0.00262	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—SST—pancreatitis	0.000101	0.0025	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—SMO—pancreatitis	0.0001	0.00248	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PTHLH—pancreatitis	0.0001	0.00248	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—SST—pancreatitis	9.88e-05	0.00244	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—SMO—pancreatitis	9.81e-05	0.00243	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PTHLH—pancreatitis	9.81e-05	0.00243	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPY—pancreatitis	9.7e-05	0.0024	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—PPP3CA—pancreatitis	9.57e-05	0.00237	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—BDKRB2—pancreatitis	9.5e-05	0.00235	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPY—pancreatitis	9.49e-05	0.00235	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—PPP3CA—pancreatitis	9.36e-05	0.00232	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CNR1—pancreatitis	9.32e-05	0.00231	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—BDKRB2—pancreatitis	9.29e-05	0.0023	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—SST—pancreatitis	9.17e-05	0.00227	CbGpPWpGaD
Levobunolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	9.15e-05	0.00226	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CNR1—pancreatitis	9.12e-05	0.00226	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—GCG—pancreatitis	9e-05	0.00223	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—SST—pancreatitis	8.97e-05	0.00222	CbGpPWpGaD
Levobunolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	8.95e-05	0.00221	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CCL2—pancreatitis	8.81e-05	0.00218	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—GCG—pancreatitis	8.81e-05	0.00218	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—KNG1—pancreatitis	8.64e-05	0.00214	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—BDKRB2—pancreatitis	8.63e-05	0.00213	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CCL2—pancreatitis	8.62e-05	0.00213	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CNR1—pancreatitis	8.47e-05	0.00209	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—KNG1—pancreatitis	8.45e-05	0.00209	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—BDKRB2—pancreatitis	8.44e-05	0.00209	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CNR1—pancreatitis	8.28e-05	0.00205	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—GCG—pancreatitis	8.18e-05	0.00202	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—GCG—pancreatitis	8e-05	0.00198	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—KNG1—pancreatitis	7.85e-05	0.00194	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—KNG1—pancreatitis	7.68e-05	0.0019	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGG—pancreatitis	7.5e-05	0.00185	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SCT—pancreatitis	7.5e-05	0.00185	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASR—pancreatitis	7.5e-05	0.00185	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CX3CL1—pancreatitis	7.35e-05	0.00182	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SCT—pancreatitis	7.33e-05	0.00181	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGG—pancreatitis	7.33e-05	0.00181	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASR—pancreatitis	7.33e-05	0.00181	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CCL5—pancreatitis	7.23e-05	0.00179	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CX3CL1—pancreatitis	7.19e-05	0.00178	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MTNR1B—pancreatitis	7.15e-05	0.00177	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCK—pancreatitis	7.15e-05	0.00177	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CCL5—pancreatitis	7.07e-05	0.00175	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCK—pancreatitis	7e-05	0.00173	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MTNR1B—pancreatitis	7e-05	0.00173	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CNR2—pancreatitis	6.97e-05	0.00172	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—A2M—pancreatitis	6.97e-05	0.00172	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TACR1—pancreatitis	6.97e-05	0.00172	CbGpPWpGaD
Levobunolol—ADRB1—GPCR ligand binding—CXCL8—pancreatitis	6.96e-05	0.00172	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCKAR—pancreatitis	6.86e-05	0.0017	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CNR2—pancreatitis	6.82e-05	0.00169	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TACR1—pancreatitis	6.82e-05	0.00169	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—A2M—pancreatitis	6.82e-05	0.00169	CbGpPWpGaD
Levobunolol—ADRB2—GPCR ligand binding—CXCL8—pancreatitis	6.81e-05	0.00169	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCKAR—pancreatitis	6.71e-05	0.00166	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL5—pancreatitis	6.56e-05	0.00162	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL5—pancreatitis	6.42e-05	0.00159	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGA—pancreatitis	6.37e-05	0.00158	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—HTR2A—pancreatitis	6.37e-05	0.00158	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGA—pancreatitis	6.24e-05	0.00154	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—HTR2A—pancreatitis	6.23e-05	0.00154	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PTHLH—pancreatitis	5.93e-05	0.00147	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SMO—pancreatitis	5.93e-05	0.00147	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—FGB—pancreatitis	5.8e-05	0.00143	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PTHLH—pancreatitis	5.8e-05	0.00143	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SMO—pancreatitis	5.8e-05	0.00143	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HTR2A—pancreatitis	5.79e-05	0.00143	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—FGB—pancreatitis	5.67e-05	0.0014	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HTR2A—pancreatitis	5.66e-05	0.0014	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PPP3CA—pancreatitis	5.65e-05	0.0014	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PPP3CA—pancreatitis	5.53e-05	0.00137	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SST—pancreatitis	5.42e-05	0.00134	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—DUSP6—pancreatitis	5.37e-05	0.00133	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SST—pancreatitis	5.3e-05	0.00131	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—DUSP6—pancreatitis	5.26e-05	0.0013	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—BDKRB2—pancreatitis	5.1e-05	0.00126	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CNR1—pancreatitis	5e-05	0.00124	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—BDKRB2—pancreatitis	4.98e-05	0.00123	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CNR1—pancreatitis	4.89e-05	0.00121	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—GCG—pancreatitis	4.83e-05	0.00119	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—GCG—pancreatitis	4.73e-05	0.00117	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KNG1—pancreatitis	4.64e-05	0.00115	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KNG1—pancreatitis	4.53e-05	0.00112	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CCL2—pancreatitis	4.52e-05	0.00112	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CCL2—pancreatitis	4.42e-05	0.00109	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—PDGFA—pancreatitis	4.26e-05	0.00105	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—PDGFA—pancreatitis	4.17e-05	0.00103	CbGpPWpGaD
Levobunolol—ADRB1—GPCR downstream signaling—CXCL8—pancreatitis	3.94e-05	0.000974	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL5—pancreatitis	3.88e-05	0.000959	CbGpPWpGaD
Levobunolol—ADRB2—GPCR downstream signaling—CXCL8—pancreatitis	3.85e-05	0.000952	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL5—pancreatitis	3.79e-05	0.000938	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LPL—pancreatitis	3.79e-05	0.000938	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LPL—pancreatitis	3.71e-05	0.000917	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—SPP1—pancreatitis	3.59e-05	0.000888	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—CXCL8—pancreatitis	3.57e-05	0.000884	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—SPP1—pancreatitis	3.51e-05	0.000869	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—CXCL8—pancreatitis	3.5e-05	0.000865	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HTR2A—pancreatitis	3.42e-05	0.000845	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HTR2A—pancreatitis	3.34e-05	0.000827	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—LEP—pancreatitis	3.18e-05	0.000786	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—LEP—pancreatitis	3.11e-05	0.000769	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—NRAS—pancreatitis	2.87e-05	0.000709	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—NRAS—pancreatitis	2.8e-05	0.000694	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—INS—pancreatitis	2.71e-05	0.000671	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CCL2—pancreatitis	2.67e-05	0.000661	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—INS—pancreatitis	2.66e-05	0.000657	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CCL2—pancreatitis	2.61e-05	0.000646	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—KRAS—pancreatitis	2.47e-05	0.00061	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—KRAS—pancreatitis	2.41e-05	0.000597	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—MDM2—pancreatitis	2.26e-05	0.000559	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—MDM2—pancreatitis	2.21e-05	0.000546	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CXCL8—pancreatitis	2.11e-05	0.000522	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—HRAS—pancreatitis	2.1e-05	0.000519	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CXCL8—pancreatitis	2.07e-05	0.000511	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—HRAS—pancreatitis	2.05e-05	0.000508	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—CASP3—pancreatitis	2.02e-05	0.0005	CbGpPWpGaD
Levobunolol—ADRB1—Signaling by GPCR—IL6—pancreatitis	2.01e-05	0.000497	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—CASP3—pancreatitis	1.98e-05	0.000489	CbGpPWpGaD
Levobunolol—ADRB2—Signaling by GPCR—IL6—pancreatitis	1.96e-05	0.000486	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—NRAS—pancreatitis	1.69e-05	0.000419	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—NRAS—pancreatitis	1.66e-05	0.00041	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—TGFB1—pancreatitis	1.57e-05	0.000389	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—TGFB1—pancreatitis	1.54e-05	0.000381	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—KRAS—pancreatitis	1.46e-05	0.000361	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—KRAS—pancreatitis	1.43e-05	0.000353	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—HRAS—pancreatitis	1.24e-05	0.000307	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—HRAS—pancreatitis	1.21e-05	0.0003	CbGpPWpGaD
Levobunolol—ADRB1—Signaling Pathways—IL6—pancreatitis	1.19e-05	0.000293	CbGpPWpGaD
Levobunolol—ADRB2—Signaling Pathways—IL6—pancreatitis	1.16e-05	0.000287	CbGpPWpGaD
